These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 10026898)

  • 1. Targeted adenoviral vectors for cancer gene therapy.
    Bilbao G; Gómez-Navarro J; Curiel DT
    Adv Exp Med Biol; 1998; 451():365-74. PubMed ID: 10026898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy: ovarian carcinoma as the paradigm.
    Gómez-Navarro J; Siegal GP; Alvarez RD; Curiel DT
    Am J Clin Pathol; 1998 Apr; 109(4):444-67. PubMed ID: 9535399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in gene therapy: averting the immune response to adenoviral vectors.
    Ritter T; Lehmann M; Volk HD
    BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer gene therapy by adenovirus-mediated gene transfer.
    Wu Q; Moyana T; Xiang J
    Curr Gene Ther; 2001 May; 1(1):101-22. PubMed ID: 12109134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral vector-mediated gene transfer for human gene therapy.
    Breyer B; Jiang W; Cheng H; Zhou L; Paul R; Feng T; He TC
    Curr Gene Ther; 2001 Jul; 1(2):149-62. PubMed ID: 12108952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral-mediated gene transfer for cancer treatment.
    Wilson DR
    Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vectors and strategies for nonviral cancer gene therapy.
    Pahle J; Walther W
    Expert Opin Biol Ther; 2016; 16(4):443-61. PubMed ID: 26761200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.
    Romanczuk H; Galer CE; Zabner J; Barsomian G; Wadsworth SC; O'Riordan CR
    Hum Gene Ther; 1999 Nov; 10(16):2615-26. PubMed ID: 10566889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GMP-Compliant Adenoviral Vectors for Gene Therapy.
    Arjmand B; Alavi-Moghadam S; Payab M; Goodarzi P; Sheikh Hosseini M; Tayanloo-Beik A; Rezaei-Tavirani M; Larijani B
    Methods Mol Biol; 2021; 2286():237-250. PubMed ID: 32504293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.
    Nettelbeck DM; Rivera AA; Kupsch J; Dieckmann D; Douglas JT; Kontermann RE; Alemany R; Curiel DT
    Int J Cancer; 2004 Jan; 108(1):136-45. PubMed ID: 14618628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helper-dependent adenoviral vectors for gene therapy.
    Palmer DJ; Ng P
    Hum Gene Ther; 2005 Jan; 16(1):1-16. PubMed ID: 15703484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral gene therapy.
    Vorburger SA; Hunt KK
    Oncologist; 2002; 7(1):46-59. PubMed ID: 11854546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-capacity adenoviral vectors for gene transfer and somatic gene therapy.
    Kochanek S
    Hum Gene Ther; 1999 Oct; 10(15):2451-9. PubMed ID: 10543611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current status of adenovirus-based cancer gene therapy.
    Shirakawa T
    Mol Cells; 2008 Jun; 25(4):462-6. PubMed ID: 18460898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
    Kasono K; Blackwell JL; Douglas JT; Dmitriev I; Strong TV; Reynolds P; Kropf DA; Carroll WR; Peters GE; Bucy RP; Curiel DT; Krasnykh V
    Clin Cancer Res; 1999 Sep; 5(9):2571-9. PubMed ID: 10499635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral and nonviral gene delivery vectors for cancer gene therapy.
    Cristiano RJ; Xu B; Nguyen D; Schumacher G; Kataoka M; Spitz FR; Roth JA
    Cancer Detect Prev; 1998; 22(5):445-54. PubMed ID: 9727626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic injection of adenoviral vectors that target gene expression to specific pituitary cell types: implications for gene therapy.
    Lee EJ; Thimmapaya B; Jameson JL
    Neurosurgery; 2000 Jun; 46(6):1461-8; discussion 1468-9. PubMed ID: 10834649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.